Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiake Xu

Showing results (91-100 of 401) with videos related to

Pageof 41
Sort By:
Current Drug Targets|June 16, 2015
Zoledronic Acid: Pleiotropic Anti-Tumor Mechanism and Therapeutic Outlook for OsteosarcomaZhengxiao Ouyang, Haowei Li, Zanjing Zhai, et al.
Tissue Engineering|March 21, 2007
Matrix-induced autologous chondrocyte implantation (MACI): biological and histological assessmentMing-Hao Zheng, Craig Willers, Lyn Kirilak, et al.
Frontiers in Genetics|April 20, 2019
Advanced Genetic Approaches in Discovery and Characterization of Genes Involved With Osteoporosis in Mouse and HumanJinbo Yuan, Jennifer Tickner, Benjamin H Mullin, et al.
Archives of Orthopaedic and Trauma Surgery|August 7, 2010
Cellular response and extracellular matrix breakdown in rotator cuff tendon ruptureBing Wu, Jimin Chen, Tammyl Dela Rosa, et al.
ACS Applied Materials & Interfaces|March 30, 2018
Reduction-Responsive Codelivery System Based on a Metal-Organic Framework for Eliciting Potent Cellular Immune ResponseYong Yang, Qianqian Chen, Jian-Ping Wu, et al.
Frontiers in Oncology|June 6, 2022
MRI Feature-Based Nomogram Model for Discrimination Between Non-Hypervascular Pancreatic Neuroendocrine Tumors and Pancreatic Ductal AdenocarcinomasJiake Xu, Jie Yang, Ye Feng, et al.
Cell Proliferation|July 26, 2021
Current research progress in targeted anti-angiogenesis therapy for osteosarcomaYun Liu, Nenggan Huang, Shijie Liao, et al.
Journal of Cellular Biochemistry|November 15, 2018
Cepharanthine suppresses osteoclast formation by modulating the nuclear factor-κB and nuclear factor of activated T-cell signaling pathwaysXixi Lin, Fangming Song, Lin Zhou, et al.
Journal of Molecular Cell Biology|April 16, 2019
PIP5k1β controls bone homeostasis through modulating both osteoclast and osteoblast differentiationXiaoying Zhao, Penglei Cui, Guoli Hu, et al.
Small (Weinheim an Der Bergstrasse, Germany)|August 25, 2018
Light-Triggered Biomimetic Nanoerythrocyte for Tumor-Targeted Lung Metastatic Combination Therapy of Malignant MelanomaWen Liu, Miaoliang Ruan, Yanming Wang, et al.
Pageof 41

Showing results (91-100 of 401) with videos related to

Sort By:
Pageof 41
Current Drug Targets|June 16, 2015
Zoledronic Acid: Pleiotropic Anti-Tumor Mechanism and Therapeutic Outlook for OsteosarcomaZhengxiao Ouyang, Haowei Li, Zanjing Zhai, et al.
Tissue Engineering|March 21, 2007
Matrix-induced autologous chondrocyte implantation (MACI): biological and histological assessmentMing-Hao Zheng, Craig Willers, Lyn Kirilak, et al.
Frontiers in Genetics|April 20, 2019
Advanced Genetic Approaches in Discovery and Characterization of Genes Involved With Osteoporosis in Mouse and HumanJinbo Yuan, Jennifer Tickner, Benjamin H Mullin, et al.
Archives of Orthopaedic and Trauma Surgery|August 7, 2010
Cellular response and extracellular matrix breakdown in rotator cuff tendon ruptureBing Wu, Jimin Chen, Tammyl Dela Rosa, et al.
ACS Applied Materials & Interfaces|March 30, 2018
Reduction-Responsive Codelivery System Based on a Metal-Organic Framework for Eliciting Potent Cellular Immune ResponseYong Yang, Qianqian Chen, Jian-Ping Wu, et al.
Frontiers in Oncology|June 6, 2022
MRI Feature-Based Nomogram Model for Discrimination Between Non-Hypervascular Pancreatic Neuroendocrine Tumors and Pancreatic Ductal AdenocarcinomasJiake Xu, Jie Yang, Ye Feng, et al.
Cell Proliferation|July 26, 2021
Current research progress in targeted anti-angiogenesis therapy for osteosarcomaYun Liu, Nenggan Huang, Shijie Liao, et al.
Journal of Cellular Biochemistry|November 15, 2018
Cepharanthine suppresses osteoclast formation by modulating the nuclear factor-κB and nuclear factor of activated T-cell signaling pathwaysXixi Lin, Fangming Song, Lin Zhou, et al.
Journal of Molecular Cell Biology|April 16, 2019
PIP5k1β controls bone homeostasis through modulating both osteoclast and osteoblast differentiationXiaoying Zhao, Penglei Cui, Guoli Hu, et al.
Small (Weinheim an Der Bergstrasse, Germany)|August 25, 2018
Light-Triggered Biomimetic Nanoerythrocyte for Tumor-Targeted Lung Metastatic Combination Therapy of Malignant MelanomaWen Liu, Miaoliang Ruan, Yanming Wang, et al.
Pageof 41